Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical Trial

Saddam Al Demour; Hanan Jafar; Sofia Adwan; Abedallatif AlSharif; Hussam Alhawari; Adel Alrabadi; Ayman Zayed; Ahmad Jaradat; Abdalla Awidi

doi:10.1159/000492120

Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical Trial

Urologia Internationalis ◽

10.1159/000492120 ◽

2018 ◽

Vol 101 (3) ◽

pp. 358-365 ◽

Cited By ~ 23

Author(s):

Saddam Al Demour ◽

Hanan Jafar ◽

Sofia Adwan ◽

Abedallatif AlSharif ◽

Hussam Alhawari ◽

...

Keyword(s):

Clinical Trial ◽

Stem Cells ◽

Bone Marrow ◽

Mesenchymal Stem Cells ◽

Erectile Dysfunction ◽

Autologous Bone Marrow ◽

Diabetic Patients ◽

Open Label ◽

Open Label Phase ◽

Autologous Bone

Download Full-text

Faculty Opinions recommendation of Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734873930.793555226 ◽

2019 ◽

Author(s):

Jason Kovac

Keyword(s):

Clinical Trial ◽

Stem Cells ◽

Bone Marrow ◽

Mesenchymal Stem Cells ◽

Erectile Dysfunction ◽

Autologous Bone Marrow ◽

Diabetic Patients ◽

Open Label ◽

Open Label Phase ◽

Autologous Bone

Download Full-text

Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction: an open-label phase 1 clinical trial

Cytotherapy ◽

10.1016/j.jcyt.2021.06.001 ◽

2021 ◽

Author(s):

Dalsan You ◽

Myoung Jin Jang ◽

Geehyun Song ◽

Ha Chul Shin ◽

Nayoung Suh ◽

...

Keyword(s):

Clinical Trial ◽

Stem Cells ◽

Bone Marrow ◽

Mesenchymal Stem Cells ◽

Phase 1 ◽

Autologous Bone Marrow ◽

Open Label ◽

Phase 1 Clinical Trial ◽

Open Label Phase ◽

Autologous Bone

Download Full-text

PD09-10 SAFETY OF AUTOLOGOUS BONE MARROW DERIVED MESENCHYMAL STEM CELLS IN ERECTILE DYSFUNCTION: AN OPEN-LABEL PHASE 1 CLINICAL TRIAL

The Journal of Urology ◽

10.1097/01.ju.0000555268.81756.b8 ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Dalasan You* ◽

Myoung Jin Jang ◽

Geehyun Song ◽

Ha Chul Shin ◽

Nayoung Suh ◽

...

Keyword(s):

Clinical Trial ◽

Stem Cells ◽

Bone Marrow ◽

Mesenchymal Stem Cells ◽

Phase 1 ◽

Autologous Bone Marrow ◽

Open Label ◽

Phase 1 Clinical Trial ◽

Open Label Phase ◽

Autologous Bone

Download Full-text

Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: A successful clinical trial in Iran

Biomedicine & Pharmacotherapy ◽

10.1016/j.biopha.2018.11.056 ◽

2019 ◽

Vol 109 ◽

pp. 1834-1840 ◽

Cited By ~ 25

Author(s):

Mohsen Ghoryani ◽

Zhaleh Shariati-Sarabi ◽

Jalil Tavakkol-Afshari ◽

Ali Ghasemi ◽

Javad Poursamimi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Stem Cells ◽

Bone Marrow ◽

Mesenchymal Stem Cells ◽

Clinical Symptoms ◽

Autologous Bone Marrow ◽

Refractory Rheumatoid Arthritis ◽

Autologous Bone

Download Full-text

Preliminary report on the safety, efficacy and functional recovery of spinal cord injury with autologous bone marrow derived mesenchymal stem cells – a clinical trial

The Internet Journal of Spine Surgery ◽

10.5580/1f26 ◽

2009 ◽

Vol 5 (1) ◽

Cited By ~ 1

Keyword(s):

Clinical Trial ◽

Spinal Cord ◽

Stem Cells ◽

Bone Marrow ◽

Spinal Cord Injury ◽

Mesenchymal Stem Cells ◽

Preliminary Report ◽

Autologous Bone Marrow ◽

Cord Injury ◽

Autologous Bone

Download Full-text

Transplantation of autologous bone marrow-derived mesenchymal stem cells under arthroscopic surgery with microfracture versus microfracture alone for articular cartilage lesions in the knee: A multicenter prospective randomized control clinical trial

Regenerative Therapy ◽

10.1016/j.reth.2019.06.002 ◽

2019 ◽

Vol 11 ◽

pp. 106-113 ◽

Cited By ~ 11

Author(s):

Yusuke Hashimoto ◽

Yohei Nishida ◽

Shinji Takahashi ◽

Hiroaki Nakamura ◽

Hisashi Mera ◽

...

Keyword(s):

Clinical Trial ◽

Stem Cells ◽

Bone Marrow ◽

Mesenchymal Stem Cells ◽

Control Clinical Trial ◽

Arthroscopic Surgery ◽

Autologous Bone Marrow ◽

Randomized Control ◽

Autologous Bone ◽

Articular Cartilage Lesions

Download Full-text

Faculty Opinions recommendation of Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.716598006.792003059 ◽

2012 ◽

Author(s):

Marc Jeschke

Keyword(s):

Stem Cells ◽

Bone Marrow ◽

Mesenchymal Stem Cells ◽

Lower Extremity ◽

Autologous Bone Marrow ◽

Autologous Bone

Download Full-text

Faculty of 1000 evaluation for Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717964446.793474530 ◽

2013 ◽

Author(s):

Christine Mummery

Keyword(s):

Stem Cells ◽

Bone Marrow ◽

Mesenchymal Stem Cells ◽

Randomized Trial ◽

Ischemic Cardiomyopathy ◽

Autologous Bone Marrow ◽

Autologous Bone

Download Full-text

Faculty Opinions recommendation of Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718318264.793494245 ◽

2014 ◽

Author(s):

Joanne Kurtzberg ◽

Jessica Sun

Keyword(s):

Bone Marrow ◽

Cerebral Palsy ◽

Phase I ◽

Phase I Trial ◽

Autologous Bone Marrow ◽

Open Label ◽

Children With Cerebral Palsy ◽

Open Label Phase ◽

Autologous Bone

Download Full-text

Faculty Opinions recommendation of Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726446689.793537589 ◽

2017 ◽

Author(s):

Isao Sakaida ◽

Taro Takami

Keyword(s):

Stem Cells ◽

Bone Marrow ◽

Mesenchymal Stem Cells ◽

Alcoholic Cirrhosis ◽

Autologous Bone Marrow ◽

Phase 2 ◽

Phase 2 Trial ◽

Autologous Bone

Download Full-text